WebMay 11, 2024 · Myomo Reports First Quarter 2024 Financial Results Revenue of $3.9 million up 66% over prior year, product revenue of $2.9 million up 23% Pipeline of 924 MyoPro candidates up 14% over fourth... WebJan 6, 2024 · BOSTON, January 06, 2024 -- ( BUSINESS WIRE )-- Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that …
Myomo Reports First Quarter 2024 Financial Results
WebMyoPro Whey Complete Whey ProteinInstantized, Chocolate - EAS1 Serving120 Calories5 g2 g20 g0.5 g40 mg1 g65 mg0 g0 g Report a problem with this food Find on Amazon Percent calories from... gramsServingoz Nutrition Facts For a Serving Size of (g) WebThe MyoPro is reportedly the first myoelectric orthotic available for home use. Regulatory . MyoPro myoelectric orthotic (brace), manufactured by Myomo, is a class II FDA registered 510(k) exempt device. Three models of MyoPro 2s are available. All MyoPro 2s are elbow-wrist-hand orthoses, featuring powered joints: tafelberg head office
Myomo scaling up distribution of MyoPro robotic arm brace
WebMyomo cost of goods sold from 2016 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an … WebA breakthrough in modern medical robotics . MyoPro is a powered arm and hand orthosis (brace) designed to help restore function to the wearer's paralyzed or weakened upper extremities, helping individuals perform actions and daily activities that might otherwise be impossible. The MyoPro may also facilitate rehabilitation including muscle re ... WebSep 21, 2024 · MyoPro is designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS, or other neuromuscular disease or injury. tafelberg primary bothasig